Cargando…

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits

Multiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under development. However, there is limited information on the quality of antibody responses generated with these vaccine modalities. To better understand antibody responses induced by spike protein-based vaccines, we p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravichandran, Supriya, Coyle, Elizabeth M., Klenow, Laura, Tang, Juanjie, Grubbs, Gabrielle, Liu, Shufeng, Wang, Tony, Golding, Hana, Khurana, Surender
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286538/ https://www.ncbi.nlm.nih.gov/pubmed/32513867 http://dx.doi.org/10.1126/scitranslmed.abc3539

Ejemplares similares

Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
por: Tang, Juanjie, et al.
Publicado: (2021)

Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures
por: Ravichandran, Supriya, et al.
Publicado: (2021)

Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients
por: Tang, Juanjie, et al.
Publicado: (2021)

Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
por: Tang, Juanjie, et al.
Publicado: (2021)

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
por: Tang, Juanjie, et al.
Publicado: (2021)

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain
por: Lee, Jeehyun, et al.
Publicado: (2021)

Human Antibody Repertoire following Ebola Virus Infection and Vaccination
por: Fuentes, Sandra, et al.
Publicado: (2020)

Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins
por: Khurana, Surender, et al.
Publicado: (2020)

Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains
por: Lee, Jeehyun, et al.
Publicado: (2018)

D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes
por: Park, Yun-Jong, et al.
Publicado: (2022)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination
por: Bellusci, Lorenza, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia
por: Bellusci, Lorenza, et al.
Publicado: (2022)

Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies
por: Ravichandran, Supriya, et al.
Publicado: (2022)

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins
por: Fuentes, Sandra, et al.
Publicado: (2016)

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
por: Ravichandran, Supriya, et al.
Publicado: (2021)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans
por: Khurana, Surender, et al.
Publicado: (2012)

Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2014)

Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
por: Khurana, Surender, et al.
Publicado: (2019)

Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto’s Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report
por: Cluff, Emily, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women
por: Lee, Youri, et al.
Publicado: (2022)

Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding
por: Struble, Lucas R., et al.
Publicado: (2022)

A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells
por: Lu, Hanxin, et al.
Publicado: (2011)

Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome
por: Ravichandran, Supriya, et al.
Publicado: (2019)

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2015)

2368. SARS-CoV-2 mRNA vaccination induces B cell immunity in the tonsils and adenoids of children
por: Xu, Qin, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children
por: Bellusci, Lorenza, et al.
Publicado: (2023)

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
por: Khurana, Surender, et al.
Publicado: (2018)

Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbits
por: O'Kennedy, Martha M, et al.
Publicado: (2023)

Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C
por: Tang, Juanjie, et al.
Publicado: (2022)

Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
por: Liu, Shufeng, et al.
Publicado: (2022)

Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
por: Alenquer, Marta, et al.
Publicado: (2021)

Preferential rabbit antibody responses to C-termini of NOTCH3 peptide immunogens
por: Lee, Soo Jung, et al.
Publicado: (2023)

Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
por: Khurana, Surender, et al.
Publicado: (2009)

Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
por: Hong, Junping, et al.
Publicado: (2021)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

ICOS(+)PD-1(+)CXCR3(+) T follicular helper cells contribute to the generation of high-avidity antibodies following influenza vaccination
por: Bentebibel, Salah-Eddine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sm3i1j1eonsc5007c6ismn0tmq